placebo of metformine, METFORMINE VIATRIS 500 mg, comprimé dispersible
APHP220832
Phase 3 small_molecule active
Quick answer
placebo of metformine, METFORMINE VIATRIS 500 mg, comprimé dispersible for Myotonic dystrophy type 1 (DM1) is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Myotonic dystrophy type 1 (DM1)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active